3-(3-chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2-one

We are 3-(3-chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2-one CAS:85175-59-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:3-(3-chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2-one
CAS.NO:85175-59-3
Synonyms:3-(3-chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2-one
3-(3-Chloropropyl)-1,3-dihydro-7,8-dimethoxy-2H-3-benzazepin-2-one
(Z)-3-(3-chloropropyl)-7,8-diethyl-1H-benzo[d]azepin-2(3H)-one
2H-3-Benzazepin-2-one,3-(3-chloropropyl)-1,3-dihydro-7,8-dimethoxy
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 484.1±45.0 °C at 760 mmHg
Molecular Formula C15H18ClNO3
Molecular Weight 295.761
Flash Point 246.6±28.7 °C
Vapour Pressure 0.0±1.2 mmHg at 25°C
Index of Refraction 1.545
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
Melting Point:105-106°C
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Ivabradine(CAS:155974-00-8) and Ivabradine hydrochloride(CAS:148849-67-6).

3-(3-chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2-one


Related News: We are pleased to work with Inceptua, given their strong record of administering such programs successfully.”/ Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday.Triisopropylsilane CAS:6485-79-6 Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday.25526-93-6 Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday.Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday.

Related Products
Product Name
S-methyl-isothiourea hydrochloride View Details
2-Bromo-3-nitrotoluene View Details
2-Aminobenzotrifluoride View Details
2-[(1R)-3-(Diisopropylamino)-1-phenylpropyl]-4-(hydroxymethyl)phe nol (2E)-2-butenedioate (1:1) manufacturer N-(2-Hydroxyethyl)piperazine manufacturer 3-Bromo-2-cyanopyridine manufacturer 1,3-phenylenediamine manufacturer [(2S,5R)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)-2,5-dihydrofuran-2-yl]methyl benzoate manufacturer